Integra Lifesciences Holdings (IART) Enterprise Value (2016 - 2025)
Integra Lifesciences Holdings (IART) has disclosed Enterprise Value for 17 consecutive years, with -$263.7 million as the latest value for Q4 2025.
- Quarterly Enterprise Value rose 3.59% to -$263.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$263.7 million through Dec 2025, up 3.59% year-over-year, with the annual reading at -$263.7 million for FY2025, 3.59% up from the prior year.
- Enterprise Value hit -$263.7 million in Q4 2025 for Integra Lifesciences Holdings, up from -$267.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$253.6 million in Q2 2025 to a low of -$663.1 million in Q1 2024.
- Historically, Enterprise Value has averaged -$369.1 million across 5 years, with a median of -$309.1 million in 2023.
- Biggest five-year swings in Enterprise Value: tumbled 115.74% in 2024 and later soared 58.79% in 2025.
- Year by year, Enterprise Value stood at -$513.4 million in 2021, then grew by 11.06% to -$456.7 million in 2022, then surged by 32.31% to -$309.1 million in 2023, then grew by 11.5% to -$273.6 million in 2024, then grew by 3.59% to -$263.7 million in 2025.
- Business Quant data shows Enterprise Value for IART at -$263.7 million in Q4 2025, -$267.9 million in Q3 2025, and -$253.6 million in Q2 2025.